Christopher R. Aker
Overview
Christopher R. Aker received an average of $797K in total compensation, including $315K in salary, at Regulus Therapeutics from 2019 to 2021.
Source: SEC filings on April 27, 2022, April 30, 2021, and April 29, 2020.
Related executives
We found ten more executives who work or worked at Regulus Therapeutics.
Joseph Hagan
Regulus Therapeutics
Chief Executive Officer
Cris Calsada
Regulus Therapeutics
Chief Financial Officer
Daniel Chevallard
Regulus Therapeutics
Chief Financial Officer
Timothy Wright
Regulus Therapeutics
Chief Research & Development Officer
Paul Grint
Regulus Therapeutics
Chief Executive Officer
Mark Deeg
Regulus Therapeutics
Chief Medical Officer
Kleanthis Xanthopoulos
Regulus Therapeutics
Chief Executive Officer
Neil Gibson
Regulus Therapeutics